CAM-IMC Score | Sensitivity (95% CI) | Specificity (95% CI) | Positive | Negative | Positive | Negative | AUROC (95% CI) | |
---|---|---|---|---|---|---|---|---|
Predictive Value (95% CI) | Likelihood-Ratio (95% CI) | |||||||
All patients (n = 624) | 3 | 0.96 (0.87-1.00) | 0.94 (0.92–0.96) | 0.62 (0.51–0.72) | 1.00 (0.90-1.00) | 17.15 (12.20-24.11) | 0.04 (0.01–0.15) | 0.95 (0.93–0.98) |
4 | 0.89 (0.77–0.96) | 0.98 (0.96–0.99) | 0.77 (0.65–0.87) | 0.99 (0.98-1.00) | 36.19 (21.39–61.23) | 0.11 (0.05–0.24) | 0.93 (0.89–0.97) | |
5 | 0.83 (0.71-0.9075) | 0.99 (0.97-1.00) | 0.87 (0.74–0.94) | 0.98 (0.97–0.99) | 67.86 (32.19-143.06) | 0.17 (0.09–0.31) | 0.91 (0.86–0.96) | |
Cognitive impairment (n = 133) | 3 | 1.00 (0.85-1.00) | 0.93 (0.86–0.97) | 0.73 (0.54–0.88) | 1.00 (0.96-1.00) | 13.87 (7.12–27.05) | 0.00 (0.00-NaN) | 0.96 (0.94–0.99) |
4 | 0.91 (0.71–0.99) | 0.97 (0.92–0.99) | 0.87 (0.66–0.97) | 0.98 (0.94-1.00) | 33.64 (10.93–103.50) | 0.09 (0.02–0.35) | 0.94 (0.88-1.00) | |
5 | 0.91 (0.71–0.99) | 1.00 (0.97-1.00) | 1.00 (0.83-1.00) | 0.98 (0.94-1.00) | Inf (NaNInf) | 0.09 (0.02–0.34) | 0.95 (0.89-1.00) | |
Age ≥ 65 years (n = 398) | 3 | 0.96 (0.86–0.99) | 0.91 (0.88–0.94) | 0.61 (0.49–0.72) | 0.99 (0.98-1.00) | 11.18 (7.90-15.82) | 0.05 (0.01–0.18) | 0.94 (0.90–0.97) |
4 | 0.92 (0.80–0.98) | 0.96 (0.94–0.98) | 0.77 (0.64–0.87) | 0.99 (0.97-1.00) | 24.68 (14.38–42.36) | 0.09 (0.03–0.22) | 0.94 (0.90–0.98) | |
5 | 0.90 (0.77–0.97) | 0.99 (0.97-1.00) | 0.86 (0.73–0.94) | 0.99 (0.97-1.00) | 44.79 (21.38–93.85) | 0.11 (0.05–0.24) | 0.94 (0.89–0.98) |